Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
NCT05145374 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2024-08-28
Summary
The objective of this proposal is to demonstrate a viable, functionally integrated multivariable artificial pancreas (mvAP) that will address meal, physical activity (PA) and acute psychological stress (APS) challenges without any manual inputs to better regulate glucose levels of people with diabetes. Acute psychological stress and many other forms of PA besides planned exercise can affect blood glucose levels and cause challenges to maintaining euglycemia for people with type 1 diabetes mellitus (T1DM). Various PA and APS affect the metabolism and sensitivity to insulin in different ways. Hence, their types, intensities and durations, and their individual and concurrent presence must be detected in order to determine the optimal insulin administration. The mvAP approach provides a well-integrated and user-friendly technology with minimal burden on the user and mitigates the effects of unexpected PA and APS inducements. Twenty subjects with type 1 diabetes (ages 18-60) who use insulin pumps enrolled in this study. The study will take place at the UIC-College of Nursing Diabetes and Exercise Laboratory. The protocol will include 1 screening visit and 5 sessions at the laboratory. The primary activities at each meeting will include: (1) screening; (2) measurement of peak exercise capacity; (3) estimation of maximal strength from submaximal strength tests; (4) Trier Social Stress Test; (5) submaximal bouts of aerobic and resistance exercise, and activities of daily living with and without stress (e.g., mental calculations, video games). These activities will be included visit 3, 4 and 5 as appropriate. In addition, subjects will perform activities at home include: housekeeping chores, stationary bike (if available); treadmill (if available); walking; and light weights (if available). Periodically, the research assistant will call the subject during these times and ask them to perform stress-inducing activities while performing the activity. The stress inducing activities will include mental challenges such as a mathematical computation while performing the activity. The subjects will be called at home 3-5 times during the study. The fully automated algorithm will be tested in a home setting, however, the methodology will be developed and approved for testing later in the study.
Conditions
Sponsors & Collaborators
-
Illinois Institute of Technology
collaborator OTHER -
University of Illinois at Chicago
lead OTHER
Principal Investigators
-
Ali Cinar · Illinois Institute of Technology
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2025-07-15
- Completion
- 2025-09-01
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin Delivery
NCT01492062 ·Status: WITHDRAWN ·Phase: NA
-
Hybrid Artificial Pancreas in Home Setting
NCT02153190 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas
NCT03859401 ·Status: COMPLETED ·Phase: NA
-
Android Artificial Pancreas System (Android APS) Versus Control-IQ
NCT05165615 ·Status: UNKNOWN ·Phase: NA
-
A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
NCT05199714 ·Status: COMPLETED ·Phase: NA
-
Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin
NCT03510000 ·Status: COMPLETED ·Phase: NA
-
Impact of Hybrid Closed Loop Systems in People With Type I Diabetes
NCT05348499 ·Status: UNKNOWN
-
Two Way Crossover Closed Loop MPC vs Control IQ
NCT05799781 ·Status: COMPLETED ·Phase: NA
-
Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC
NCT03428295 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)
NCT01472406 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Relieving Carb Counting Via Flexible-userinteraction Multiple-input Control Architectures
NCT07031492 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Artificial Pancreas Control System in an Inpatient Setting
NCT01552603 ·Status: COMPLETED ·Phase: PHASE2
-
Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients
NCT03353792 ·Status: TERMINATED ·Phase: NA
-
Insulet Artificial Pancreas Early Feasibility Study
NCT02897557 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin
NCT03804983 ·Status: COMPLETED ·Phase: NA
-
Controlled Insulin Delivery: Combining Technology With Treatment
NCT01484457 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting
NCT04793165 ·Status: COMPLETED ·Phase: NA
-
Nocturnal Insulin-Glucose in Hospital: Tight Control
NCT02160184 ·Status: COMPLETED ·Phase: NA
-
Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study
NCT01800734 ·Status: UNKNOWN ·Phase: PHASE4
-
Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas
NCT01161862 ·Status: COMPLETED ·Phase: NA
-
Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System
NCT04450563 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
NCT06081231 ·Status: RECRUITING
-
Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index
NCT03092310 ·Status: COMPLETED ·Phase: NA
-
Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation
NCT04510506 ·Status: COMPLETED ·Phase: NA
-
Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting
NCT03979352 ·Status: COMPLETED ·Phase: PHASE3